Opinion

Video

Quality of Life & Patient Reported Outcomes in Dry Eye Disease

Panelists underscore the importance of patient education in improving treatment adherence.

This is a video synopsis/summary of a Stakeholder Summit involving:

Ryan Haumschild, PharmD, MS, MBA; Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD.

Kabiri discusses the significant impact of dry eye disease (DED) on quality of life, including higher rates of depression compared to other ocular conditions. Red, irritated eyes also affect self-image and enjoyment of activities. Patient perspectives on DED help identify educational gaps for improved adherence.

Haumschild then asks about strategies to improve DED adherence. Parekh notes the value of direct-to-consumer DED awareness campaigns in informing patients and driving inquiries regarding specialty care. Education around DED encompasses digital patient communities, eye care team counseling, pharmacy staff, professional societies, and industry. With DED’s rising prominence, education helps prevent misinformation, empowers patients to seek appropriate treatment, and facilitates proper self-management for better outcomes.

Video synopsis is AI-generated and reviewed by AJMCÒ editorial staff.

Related Videos
Parth Rali, MD
1 KOL is featured in this series.
4 KOLs are featured in this series
4 KOLs are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo